Jee-Sun Cho
Senior Programme Manager
Jee-Sun joined the Draper Lab in 2017 as a postdoctoral scientist, contributing to pre-clinical malaria vaccine development and early controlled human infection studies before transitioning into clinical project management in 2020. She is now a Senior Clinical Trials Project Manager in the Department of Paediatrics, where she leads the delivery of multiple phase I/II malaria vaccine trials and human challenge studies. Her responsibilities span full life-cycle trial oversight, including regulatory and ethical submissions, site management, monitoring coordination, participant recruitment strategy, contract negotiation, financial management, and investigational medicinal product oversight. She collaborates closely with clinicians, scientists, regulatory bodies, and funders to ensure high-quality trial conduct, robust governance, and timely delivery of project milestones.
Recent publications
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Journal article
Silk SE. et al, (2024), Lancet Infect Dis, 24, 1105 - 1117
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Journal article
Silk SE. et al, (2023), Med, 4, 668 - 686.e7
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Journal article
Hou MM. et al, (2023), Sci Transl Med, 15
Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
Journal article
Rawlinson TA. et al, (2019), Nat Microbiol, 4, 1497 - 1507
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages.
Journal article
Chua ACY. et al, (2019), Nat Commun, 10